• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

0.6370 +0.0010 (+0.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lexaria Bioscience Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
News headline image
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
June 03, 2026
Via ACCESS Newswire
News headline image
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
May 19, 2026
Via ACCESS Newswire
News headline image
Lexaria Bioscience Releases Second Episode of Investor Video Series
May 07, 2026
Via ACCESS Newswire
News headline image
Lexaria Updates Progress on Human Study #7
May 05, 2026
Via ACCESS Newswire
News headline image
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications
May 01, 2026
Via ACCESS Newswire
Wednesday's session: top gainers and losers ↗
April 29, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
April 29, 2026
Via Chartmill
News headline image
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
April 29, 2026
Via ACCESS Newswire
News headline image
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
April 23, 2026
Via ACCESS Newswire
News headline image
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales
April 21, 2026
Via ACCESS Newswire
News headline image
Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property
April 15, 2026
Via ACCESS Newswire
News headline image
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
Via ACCESS Newswire
News headline image
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
The number of oral weight-loss / diabetes drug treatments is expanding, increasing demand for the reduction of side effects 
Via TheNewswire.com
News headline image
Lexaria to Begin New Human Clinical Study in GLP-1
April 01, 2026
Via ACCESS Newswire
News headline image
Lexaria's Robust Patent Portfolio Continues to Grow
March 26, 2026
Via ACCESS Newswire
News headline image
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
March 24, 2026
Via ACCESS Newswire
News headline image
Lexaria Announces New R&D Plans for 2026
March 04, 2026
Via ACCESS Newswire
News headline image
Lexaria Announces Positive Final Results From Human Pilot Study #5
February 05, 2026
Via ACCESS Newswire
News headline image
Lexaria Awarded Six Additional Patents
January 22, 2026
Lexaria now has 60 patents granted around much of the world 
Via TheNewswire.com
Topics Intellectual Property
News headline image
Lexaria Awarded Six Additional Patents
January 22, 2026
Via ACCESS Newswire
News headline image
Lexaria Releases Annual Letter from the CEO
January 12, 2026
Via ACCESS Newswire
News headline image
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
January 21, 2026
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. 
From USA News Group
Via GlobeNewswire
News headline image
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
December 30, 2025
Via ACCESS Newswire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
December 26, 2025
Unusual volume stocks are being observed in Friday's session. 
Via Chartmill
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
December 24, 2025
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
December 23, 2025
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 16, 2025
Via ACCESS Newswire
News headline image
Which stocks are moving on Monday? ↗
December 15, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Which stocks are gapping on Monday? ↗
December 15, 2025
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
Monday's pre-market session: top gainers and losers ↗
December 15, 2025
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap